Steven L. Cook, serving as the Chief Financial Officer for Omada Health Inc. (NASDAQ:OMDA), completed a sale of company equity on July 13, 2026. The transaction involved the disposal of 5,800 shares of common stock, generating total proceeds of $139,206. These shares were sold at prices ranging between $24.00 and $24.01 per share. The execution of this sale was conducted in compliance with a pre-arranged 10b5-1 trading plan that Mr. Cook established on March 14, 2026.
Earlier in the same trading session, Mr. Cook acquired the identical quantity of 5,800 shares through the exercise of stock options. The acquisition was priced at an exercise rate of $8.28 per share, resulting in a total cost of $48,023 for the options. At the time of exercise, all underlying options were fully vested and immediately exercisable. Following these sequential transactions, Mr. Cook's direct ownership in Omada Health stands at 187,209 shares. Additionally, he maintains a position of 261,845 derivative securities classified as stock options.
The stock activity occurs against a backdrop of recent corporate developments and market performance. Omada Health's shares have appreciated by 50% over the trailing six-month period, trading at $23.73 at the time of the reported transaction. Market valuation analysis from InvestingPro indicates that the stock is currently priced above its estimated Fair Value, categorizing it among companies exhibiting significant overvaluation relative to intrinsic metrics.
Financially, Omada Health reported first-quarter 2026 results that surpassed consensus expectations. The company posted a loss per share of -$0.05, outperforming the forecasted loss of -$0.08. Top-line revenue for the quarter reached $78 million, marking a 42% year-over-year increase. In response to these results, Citizens adjusted its price target for Omada Health upward to $21 from $18, while maintaining a Market Outperform rating. Analyst Constantine Davides noted that the stock has been trading at a multiple of 2.5 times the firm's 2026 revenue estimate since its initial public offering in June 2025.
In governance matters, Omada Health concluded its 2026 Annual Meeting of Stockholders. During this meeting, Sean Duffy and Trevor Fetter were elected as Class I Directors. Both individuals are scheduled to serve their terms until the 2029 annual meeting. The combination of executive stock activity, financial reporting beats, and board composition changes underscores a period of heightened operational and market engagement for the company.